Cargando…
Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma
Improving treatment of advanced melanoma may require the development of effective strategies to overcome resistance to different anti-tumor agents and to counteract relevant pro-tumoral mechanisms in the microenvironment. Here we provide preclinical evidence that these goals can be achieved in most...
Autores principales: | Grazia, G, Vegetti, C, Benigni, F, Penna, I, Perotti, V, Tassi, E, Bersani, I, Nicolini, G, Canevari, S, Carlo-Stella, C, Gianni, A M, Mortarini, R, Anichini, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649516/ https://www.ncbi.nlm.nih.gov/pubmed/25275595 http://dx.doi.org/10.1038/cddis.2014.410 |
Ejemplares similares
-
Correction to: NFATc2 is an intrinsic regulator of melanoma dedifferentiation
por: Perotti, V., et al.
Publicado: (2019) -
An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells
por: Perotti, Valentina, et al.
Publicado: (2019) -
Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3
por: Lai, F, et al.
Publicado: (2013) -
Towards combinatorial targeted therapy in melanoma: From pre-clinical evidence to clinical application (Review)
por: GRAZIA, GIULIA, et al.
Publicado: (2014) -
Immune Escape Mechanisms in Non Small Cell Lung Cancer
por: Anichini, Andrea, et al.
Publicado: (2020)